Aslan Pharmaceuticals Ltd ASLN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:58 PM EDT
0.48quote price arrow up+0.0066 (+1.4043%)
Volume
31,392
Close
0.47quote price arrow up+0.001 (+0.2132%)
Volume
943,426
52 week range
0.39 - 4.69
Loading...
  • Open0.47
  • Day High0.4986
  • Day Low0.4501
  • Prev Close0.469
  • 52 Week High4.69
  • 52 Week High Date05/12/23
  • 52 Week Low0.39
  • 52 Week Low Date12/26/23

Key Stats

  • Market Cap425,382.912
  • Shares Out905,070.01
  • 10 Day Average Volume1.42M
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • YTD % Change-9.98

KEY STATS

  • Open0.47
  • Day High0.4986
  • Day Low0.4501
  • Prev Close0.469
  • 52 Week High4.69
  • 52 Week High Date05/12/23
  • 52 Week Low0.39
  • 52 Week Low Date12/26/23
  • Market Cap425,382.912
  • Shares Out905,070.01
  • 10 Day Average Volume1.42M
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • YTD % Change-9.98

RATIOS/PROFITABILITY

  • EPS (TTM)-3.01
  • P/E (TTM)-0.16
  • Fwd P/E (NTM)-0.20
  • EBITDA (TTM)-44.283M
  • ROE (TTM)-426.64%
  • Revenue (TTM)12.00M
  • Gross Margin (TTM)100.00%
  • Net Margin (TTM)-376.57%
  • Debt To Equity (MRQ)-4,346.81%

EVENTS

  • Earnings Date04/26/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aslan Pharmaceuticals Ltd

 

Profile

MORE
ASLAN Pharmaceuticals Limited is a clinical-stage immunology focused biopharmaceutical company. The Company's portfolio is led by eblasakimab (ASLAN004), a potential human monoclonal antibody that binds to the IL-13 receptor a1 subunit (IL-13Ra1), blocking signaling of two pro-inflammatory cytokines, IL-4 and IL-13, which are central to triggering symptoms of atopic dermatitis, such as redness and itching of the skin. It is conducting a Phase II b clinical trial investigating...
Andrew Howden
Independent Chairman of the Board
Carl Firth Ph.D.
Chief Executive Officer, Director
Kiran Asarpota
Chief Operating Officer, Head of Finance
Ben Goodger
General Counsel
Address
83 Clemenceau Avenue, #12-03 Ue Square
239920
Singapore